Los Angeles Capital Management & Equity Research Inc. Has $124.02 Million Position in UnitedHealth Group Inc (UNH)
Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 10.2% in the third quarter, Holdings Channel reports. The firm owned 633,239 shares of the healthcare conglomerate’s stock after buying an additional 58,365 shares during the period. UnitedHealth Group makes up approximately 0.7% of Los Angeles Capital Management & Equity Research Inc.’s investment portfolio, making the stock its 20th largest position. Los Angeles Capital Management & Equity Research Inc.’s holdings in UnitedHealth Group were worth $124,020,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Blue Chip Partners Inc. purchased a new stake in UnitedHealth Group in the second quarter valued at about $110,000. Bruderman Asset Management LLC purchased a new stake in UnitedHealth Group in the second quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after buying an additional 520 shares during the last quarter. BDO Wealth Advisors LLC purchased a new stake in UnitedHealth Group in the second quarter valued at about $121,000. Finally, Acrospire Investment Management LLC raised its stake in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after buying an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 86.01% of the company’s stock.
A number of research firms have commented on UNH. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Citigroup increased their price target on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. BMO Capital Markets began coverage on UnitedHealth Group in a research note on Monday, October 16th. They issued an “outperform” rating and a $250.00 price target for the company. Finally, Jefferies Group reiterated a “buy” rating and issued a $248.00 price target on shares of UnitedHealth Group in a research note on Friday, December 1st. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $226.74.
In related news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,630 shares of company stock worth $7,669,416. 0.89% of the stock is owned by corporate insiders.
UnitedHealth Group Inc (UNH) opened at $225.39 on Friday. The firm has a market capitalization of $217,920.00, a PE ratio of 25.61, a PEG ratio of 1.57 and a beta of 0.66. UnitedHealth Group Inc has a 1-year low of $156.09 and a 1-year high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the company earned $2.17 earnings per share. sell-side analysts anticipate that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This report was first published by Daily Political and is the property of of Daily Political. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/12/los-angeles-capital-management-equity-research-inc-has-124-02-million-position-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.